Evidence for a trigger function of valproic acid in xenobiotic-induced hepatotoxicity

Pharmacology and Toxicology

Volumn 87, Issue 2, 2000, Pages 89-95

  Klee, Sabine ^a   Johanssen, Sandra ^a   Ungemach, Fritz Rupert ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; LACTATE DEHYDROGENASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; VALPROIC ACID;

ANIMAL CELL; ANTICONVULSANT THERAPY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; EPILEPSY; LIVER CELL; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; XENOBIOTIC METABOLISM;

ANIMALIA;

EID: 0033887661     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2000.d01-50.x     Document Type: Article

References (50)

1. Anderson, G. D.: A mechanistic approach to antiepileptic drug interactions. Ann. Pharmacotherap. 1998, 32, 554-563.
2. Baillie, T. A. & A. W. Rettenmeier: Valproate: biotransformation. In: Antiepileptic drugs. Eds.: R. H. Levy, F. E. Dreifuss, R. M. Mattson, B. S. Meldrum & J. K. Penry. Raven Press, New York, USA, 1989, pp. 601-619.
3. Baur, H., S. Kasperek & E. Pfaff: Criteria of viability of isolated liver cells. Hoppe-Seylers Z. Physiol Chem. 1975, 356, 827-838.
4. Beauchamp, R. O., Jr., D. A. Andjelkovich, A. D. Kligerman, K. T. Morgan & H. d'A. Heck: A critical review of the literature on acrolein toxicity. CRC Crit. Rev. Toxicol. 1985, 14, 309-378.
5. Bjorge, S. M. & T. A. Baillie: Studies on the β-oxidation of valproic acid in rat liver mitochondrial preparations. Drug Metab. Dispos. 1991, 19, 823-829.
6. Cotariu, D., S. Evans, J. L. Zaidman & O. Marcus: Early changes in hepatic redox homeostasis following treatment with a single dose of valproic acid. Biochem. Pharmacol. 1990, 40, 589-593.
7. Cotariu, D., S. Evans, E. Lahat, J. Theitler, T. Bistritzer & J. L. Zaidman: Inhibition of human red blood cell glutathione reductase by valproic acid. Biochem. Pharmacol 1992, 43, 425-429.
8. Dawson, J. R., K. Norbeck, I. Anundi & P. Moldeus: The effectiveness of N-acetylcysteine in isolated hepatocytes, against the toxicity of paracetamol, acrolein, and paraquat. Arch. Toxicol. 1984, 55, 11-15.
9. Davis, R., D. H. Peters & D. McTavish: Valproic acid - a reappraisal of its pharmacological properties and clinical efficacy in epilepsy. Drugs 1994, 47, 332-372.
10. De Vries, N. & S. De Flora: N-acetyl-cysteine. J. Cell. Biochem. 1993, Suppl. 17F, 270-277.
11. Fromenty, B. & D. Pessayre: Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines. J. Hepatol. 1997, 26 Suppl. 2, 43-53.
12. Gad, S. C. & C. S. Weil: Statistics for toxicologists. In: Principles and methods of toxicology. Ed.: W. Hayes. Raven Press, New York, USA, 1989, pp. 454-455.
13. Gidal, B. E., M. E. Pitterle, N. W. Spencer & M. M. Maly: Relationship between valproic acid dosage, plasma concentration and clearance in adult monotherapy patients with epilepsy. J. Clin. Pharm. Therap. 1995, 20, 215-219.
14. Glascott, P. E., E. Gilfor, A. Serroni & J. L. Farber: Independent antioxidant action of vitamins E and C in cultured rat hepatocytes intoxicated with allyl alcohol. Biochem. Phannacol. 1996, 52, 1245-1252.
15. Granneman, G. R., S. I. Wang, J. W. Kesterson & J. M. Machinist: The hepatotoxicity of valproic acid and its metabolites in rats. II. Intermediary and valproic acid metabolism. Hepatology 1984, 4, 1153-1158.
16. Gregus, Z., T. Fekete, F. Varga & C. D. Klaassen: Effect of valproic acid on glycine conjugation of benzoic acid. J. Pharmacol. Exp. Therap. 1993, 267, 1068-1075.
17. Griffith, O. W: Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 1980, 106, 207-212.
18. Gurtoo, H. L., J. H. Hipkens & S. D. Sharma: Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide. Cancer Res. 1981, 41, 3584-3591.
19. Ito, M., Y. Ikeda, J. G. Arnez, G. Finocchiaro & K. Tanaka: The enzymatic basis for the metabolism and inhibitory effects of valproic acid: dehydrogenation of valproyl-CoA by 2-methyl-branched-chain acyl-CoA dehydrogenase. Biochim. Biophys. Acta 1990, 1034, 213-218.
20. Jaeschke, H., C. Kleinwaechter & A. Wendel: The role of acrolein in allyl alcohol-induced lipid peroxidation and liver cell damage in mice. Biochem. Pharmacol. 1987, 36, 51-57.
21. 3-induced cytotoxicity in isolated rat hepatocytes. Pharmacology & Toxicology 1994, 75, 7-16.
22. Jurima-Romet, M., F. S. Abbott, W. Tang, H. S. Huang & L. W. Whitehouse: Cytotoxicity of unsaturated metabolites of valproic acid and protection by vitamins C and E in glutathione-depleted rat hepatocytes. Toxicology 1996, 112, 69-85.
23. Kassahun, K., K. Farrell & F. Abbott: Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans. Drug Metab. Disp. 1991, 19, 525-535.
24. Kassahun, K., P. Hu, M. P. Grillo, M. R. Davis, L. Jin & T. A. Baillie: Metabolic activation of unsaturated derivatives of valproic acid. Identification of novel glutathione adducts formed through coenzyme A-dependent and -independent processes. Chem. Biol. Interact. 1994, 90, 253-275.
25. Kesterson, J. W., G. R. Granneman & J. M. Machinist: The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies. Hepatology 1984, 4, 1143-1152.
26. Khan, S &. P. J. O'Brien: 1-Bromoalkanes as new potent nontoxic glutathione depletors in isolated rat hepatocytes. Biochem. Biophys. Res. Commun. 1991, 179, 436-441.
27. Klee, S., M. C. Nürnberger & F. R. Ungemach: The consequences of nitrofurantoin-induced oxidative stress in isolated rat hepatocytes: evaluation of pathobiochemical alterations. Chem. Biol. Interact. 1994, 93, 91-102.
28. Kresze, G.-B.: The biuret method. In: Methods of enzymatic analysis. Vol. II. Ed.: H. U. Bergmeyer. Verlag Chemie, Weinheim, Germany, 1988, pp. 86-87.
29. Lake, B. G., S. D. Gangolli, M. G. Wright, P. Grasso, F. M. Carpanini & K. R. Butterworth: The effect of repeated administration on allyl alcohol-induced hepatotoxicity in the rat. Biochem. Soc. Trans. 1978, 6, 145-147.
30. Levy, R. H., A. W. Rettenmeier, G. D. Anderson, A. J. Wilensky, P. N. Friel, T. A. Baillie, A. Acheampong, J. Tor, M. Guyot & P. Loiseau: Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acid. Clin. Pharmacol. Therap. 1990, 48, 225-235.
31. Maellaro, E., A. F. Casini, B. Del Bello & M. Comporti: Lipid peroxidation and antioxidant systems in the liver injury produced by glutathione depleting agents. Biochem. Pharmacol. 1990, 39, 1513-1521.
32. Meredith, M. J. & D. J. Reed: Status of the mitochondrial pool of glutathione in the isolated hepatocyte. J. Biol. Chem. 1982, 257, 3747-3753.
33. Nordhoff, A., R. H. Schirmer, E. Mayatepek & K. Becker: No evidence for inhibition of human glutathione reductase by valproic acid. Biochem. Pharmacol. 1994, 47, 1453-1456.
34. Ohkawa, H.: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95, 351-358.
35. Ohno, Y., K. Ormstad, D. Ross & S. Orrenius: Mechanism of allyl alcohol toxicity and protective effects of low-molecular-weight thiols studied with isolated rat hepatocytes. Toxicol. Appl. Pharmacol. 1985, 68, 169-179.
36. Pompella, A., A. Romani, A. Benedetti & M. Comporti: Loss of membrane protein thiols and lipid peroxidation in allyl alcohol hepatotoxicity. Biochem. Pharmacol. 1991, 41, 1255-1259.
37. Ponchaut, S., J. P. Draye, K. Veitch & F. van Hoof: Influence of chronic administration of valproate on ultrastructure and enzyme content of peroxisomes in rat liver and kidney. Biochem. Pharmacol. 1991, 41, 1419-1428.
38. Ponchaut, S. & K. Veitch: Valproate and mitochondria. Biochem. Pharmacol. 1993, 46, 199-204.
39. Porubek, D. J., M. P. Grillo & T. A. Baillie: The covalent binding of valproic acid and its hepatotoxic metabolite, 2-n-propyl-4-pentenoic acid, in rats and in isolated rat hepatocytes. Drug Metab. Disp. 1989, 17, 123-130.
40. Redegeld, F. A., R. M. Moison, A. S. Koster & J. Noordhoek: Depletion of ATP but not of GSH affects viability of rat hepatocytes. Eur. J. Pharmacol. 1992, 228, 229-236.
41. Richman, P. G. & A. Meister: Regulation of γ-glutamyl-cysteine synthetase by nonallosteric feedback inhibition by glutathione. J. Biol. Chem. 1975, 250, 1422-1426.
42. Rikans, L. E., D. Y. Cai & K. R. Hornbook: Loss of mitochondrial membrane potential is not essential to hepatocyte killing by allyl alcohol. Toxicol. Letters 1995, 81, 159-165.
43. Roberts, E. A.: Pediatric hepatic drug reactions. In: Drug-induced hepatotoxicity. Handbook of Experimental Pharmacology, Vol. 121. Eds.: R.G. Cameron, G. Feuer & F.A. de la Iglesia. Springer Verlag, Berlin, Germany, 1996, pp. 293-322.
44. Rogiers, V., A. Callaerts, A. Vercruysse, M. Akrawi, E. Shephard & I. Phillips: Effects of valproate on xenobiotic biotransformation in rat liver. In vivo and in vitro experiments. Pharm. Weekbl. Sci. 1992, 14, 127-131.
45. Rogiers, V., M. Akrawi, A. Vercruysse, I. R. Phillips & E. A. Shephard: Effects of the anticonvulsant, valproate, on the expression of components of the cytochrome-P-450-mediated monooxygenase system and glutathione S-transferases. Eur. J. Biochem. 1995, 231, 337-343.
46. Siemes, H., H. Nau, K. Schultze, W. Wittfoht, E. Drews, J. Penzien & U. Seidel: Valproate (VPA) metabolites in various clinical conditions of probable VPA-associated hepatotoxicity. Epilepsia 1993, 34, 332-346.
47. Tang, W., A. G. Borel, T. Fujimiya & F. S. Abbott: Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status. Chem. Res. Toxicol. 1995, 8, 671-682.
48. Tang, W., A. G. Borel & F. S. Abbott: Conjugation of glutathione with a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, catalyzed by rat hepatic glutathione-S-transferases. Drug Metab. Disp. 1996, 24, 436-446.
49. Vance, M. A., P. D. Gray & K. G. Tolman: Effect of glycine on valproate toxicity in rat hepatocytes. Epilepsia 1994, 35, 1016-1022.
50. Zimmerman, H. J. & K. G. Ishak: Antiepileptic drugs. In: Drug-induced hepatotoxicity. Handbook of Experimental Pharmacology, Vol.121. Eds.: R. G. Cameron, G. Feuer & F. A. de la Iglesia. Springer Verlag, Berlin, Heidelberg, Germany, 1996, pp. 637-662.